dextromethorphan hydrobromide is one of 109 small molecule programs targeting Breast Cancer. It is currently in Preclinical.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
744 competitors in Breast Cancer
Adenocard
Voltaren
Zolymbus
MS Contin
Duragesic-100
MS Contin
Spravato
Tricor
Cortef
Acupan
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details